EMFLAZA

Product NDC: 52856-503
11-digit product format: 528560503
Labeler code: 52856
Product ID: 52856-503_2b07ec82-2eb4-4a87-9787-9c2db6a0649b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: deflazacort
Dosage form: TABLET
Route: ORAL
Labeler: PTC Therapeutics, Inc.
Application: NDA208684
Marketing category: NDA
Marketing start: 2018-09-10
Substance: DEFLAZACORT
Active strength: 30 mg/1
Pharmacologic classes: Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N208684-001	EMFLAZA	DEFLAZACORT	6MG	TABLET / ORAL	AB	RLD	2017-02-09
N208684-002	EMFLAZA	DEFLAZACORT	18MG	TABLET / ORAL	AB	RLD	2017-02-09
N208684-003	EMFLAZA	DEFLAZACORT	30MG	TABLET / ORAL	AB	RLD	2017-02-09
N208684-004	EMFLAZA	DEFLAZACORT	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
N208684-001	AB
N208684-002	AB
N208684-003	AB
N208684-004	AB

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 4 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N208684-001	ODE-252	2026-06-07
N208684-002	ODE-252	2026-06-07
N208684-003	ODE-252	2026-06-07
N208684-004	ODE-252	2026-06-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208684-001	EMFLAZA	6MG	TABLET / ORAL	AB	RLD	2017-02-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208684-002	EMFLAZA	18MG	TABLET / ORAL	AB	RLD	2017-02-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208684-003	EMFLAZA	30MG	TABLET / ORAL	AB	RLD	2017-02-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208684-004	EMFLAZA	36MG	TABLET / ORAL	AB	RLD, RS	2017-02-09	`2680178bc6a6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 76 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	N208684-001	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N208684-002	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N208684-003	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N208684-004	AB	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N208684-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208684-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208684-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N208684-004	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N208684-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208684-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208684-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N208684-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N208684-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208684-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208684-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N208684-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208684-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208684-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208684-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N208684-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N208684-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208684-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208684-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N208684-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208684-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208684-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208684-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N208684-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208684-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208684-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208684-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N208684-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208684-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208684-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208684-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N208684-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208684-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208684-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208684-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N208684-004	AB	1	`2680178bc6a6…`

Observed Orange Book exclusivity history#

Exclusivity history page 9 of 10 · 380 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2023-01-26 05:58 UTC	2023-01	N208684-002	ODE-130	2024-02-09	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N208684-002	ODE-252	2026-06-07	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N208684-003	NCE	2022-02-09	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N208684-003	ODE-130	2024-02-09	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N208684-003	ODE-252	2026-06-07	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N208684-004	NCE	2022-02-09	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N208684-004	ODE-130	2024-02-09	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N208684-004	ODE-252	2026-06-07	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-001	NCE	2022-02-09	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-001	ODE-130	2024-02-09	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-001	ODE-252	2026-06-07	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-002	NCE	2022-02-09	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-002	ODE-130	2024-02-09	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-002	ODE-252	2026-06-07	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-003	NCE	2022-02-09	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-003	ODE-130	2024-02-09	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-003	ODE-252	2026-06-07	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-004	NCE	2022-02-09	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-004	ODE-130	2024-02-09	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N208684-004	ODE-252	2026-06-07	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N208684-001	NCE	2022-02-09	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-001	ODE-130	2024-02-09	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-001	ODE-252	2026-06-07	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-002	NCE	2022-02-09	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-002	ODE-130	2024-02-09	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-002	ODE-252	2026-06-07	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-003	NCE	2022-02-09	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-003	ODE-130	2024-02-09	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-003	ODE-252	2026-06-07	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-004	NCE	2022-02-09	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-004	ODE-130	2024-02-09	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N208684-004	ODE-252	2026-06-07	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N208684-001	NCE	2022-02-09	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N208684-001	ODE-130	2024-02-09	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N208684-001	ODE-252	2026-06-07	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N208684-002	NCE	2022-02-09	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N208684-002	ODE-130	2024-02-09	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N208684-002	ODE-252	2026-06-07	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N208684-003	NCE	2022-02-09	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N208684-003	ODE-130	2024-02-09	`e64feba35796…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: EMFLAZA
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DEFLAZACORT	30 mg/1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
890642af-0787-4d04-9130-a3ba5909cd85	Product name	5	20260106
48747306-602a-42cc-957b-5b0c69158eee	Product name	1	20180604
6084a4f4-5437-c9a5-caec-5361ee075a59	Product name	1	20140508
90c5639a-61b0-88d6-ddcf-21888e94869a	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
9869efd7-d6dd-0665-5b67-53adbe6ef15e	Product name	1	20140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
Effective	Related label
2023-02-21	These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 2017
2023-02-21	These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 2017
2023-01-30	These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 2017
2023-01-30	These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 2017

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
52856-503-03	EMFLAZA	30 in 1 BOTTLE	TABLET	30		21

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
52856-503-03	EA - Each	52856-503	116cc16d-3a0e-4136-8a74-f9c4d5dba369	1	2018-11-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52856-503	EMFLAZA (DEFLAZACORT) TABLET EMFLAZA (DEFLAZACORT) SUSPENSION [PTC THERAPEUTICS, INC.]	20	Current NDC, Legacy NDC, 1 package rows	20241220_31b347d2-f156-4055-9d8f-7cf0df420296.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
KR5YZ6AE4B	DEFLAZACORT	14484-47-0	DEFLAZACORT

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1870954	deflazacort 18 MG Oral Tablet	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870964	deflazacort 22.75 MG/mL Oral Suspension	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
153880	deflazacort 30 MG Oral Tablet	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870958	deflazacort 36 MG Oral Tablet	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
153098	deflazacort 6 MG Oral Tablet	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870956	Emflaza 18 MG Oral Tablet	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870968	Emflaza 22.75 MG/mL Oral Suspension	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870952	Emflaza 30 MG Oral Tablet	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870960	Emflaza 36 MG Oral Tablet	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870950	Emflaza 6 MG Oral Tablet	PSN	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870956	deflazacort 18 MG Oral Tablet [Emflaza]	SBD	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870968	deflazacort 22.75 MG/ML Oral Suspension [Emflaza]	SBD	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870952	deflazacort 30 MG Oral Tablet [Emflaza]	SBD	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870960	deflazacort 36 MG Oral Tablet [Emflaza]	SBD	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870950	deflazacort 6 MG Oral Tablet [Emflaza]	SBD	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870954	deflazacort 18 MG Oral Tablet	SCD	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870964	deflazacort 22.75 MG/ML Oral Suspension	SCD	31b347d2-f156-4055-9d8f-7cf0df420296	21
153880	deflazacort 30 MG Oral Tablet	SCD	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870958	deflazacort 36 MG Oral Tablet	SCD	31b347d2-f156-4055-9d8f-7cf0df420296	21
153098	deflazacort 6 MG Oral Tablet	SCD	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870956	Emflaza 18 MG Oral Tablet	SY	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870968	Emflaza 22.75 MG/ML Oral Suspension	SY	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870952	Emflaza 30 MG Oral Tablet	SY	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870960	Emflaza 36 MG Oral Tablet	SY	31b347d2-f156-4055-9d8f-7cf0df420296	21
1870950	Emflaza 6 MG Oral Tablet	SY	31b347d2-f156-4055-9d8f-7cf0df420296	21

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
52856-503-03	52856050303	30 TABLET in 1 BOTTLE (52856-503-03)	30 tablet	2018-09-10	0000-00-00	No	No	Current